BRIEF: Burning Rock returns to revenue growth as loss narrows
Cancer screening company Burning Rock Biotech Ltd. (BNR.US) on Wednesday reported its revenue rose 0.8% in the third quarter year-on-year to 128.6 million yuan ($17.6 million), as it returned to…
New Horizon Health finds formula for profits ahead of schedule
One of China’s leading makers of early cancer screening products recorded an adjusted profit in the first half of the year as its revenue more than tripled Key Takeaways: New…
New Horizon’s Sales Surge as China Promotes Early Cancer Detection
Company’s first-mover advantage in at-home colorectal screening and China’s focus on early detection have turbocharged sales, though valuation remains frothy Key takeaways: New Horizon’s first-half revenues jumped more than fourfold,…
RECENT ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
Yalla revenue growth returns to double-digits ahead of new gaming push
YALA.US
-
Baozun returns to the black as Gap expansion accelerates
9991.HK BZUN.US
-
Cango gets crypto jolt back to revenue growth, profitability
CANG.US
-
BRIEF: Ubtech revenue grows, loss narrows in 2024
9880.HK
